Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Clin Gastroenterol Hepatol. 2024 Oct;22(10):2033-2043.e2. doi: 10.1016/j.cgh.2024.05.039. Epub 2024 Jun 12.
BACKGROUND & AIMS: Acute pancreatitis (AP) is increasingly recognized as a risk factor for diabetes mellitus (DM). We aimed to study the association of pancreatitis genes with pancreatic endocrine insufficiency (pre-DM and DM) development post-AP in children.
This was an observational cohort study that enrolled subjects ≤21 years with their first episode of AP and followed them for 12 months for the development of pancreatic endocrine insufficiency. Pancreatitis risk genes (CASR, CEL, CFTR, CLDN2, CPA1, CTRC, PRSS1, SBDS, SPINK1, and UBR1) were sequenced. A genetic risk score was derived from all genes with univariable P < .15.
A total 120 subjects with AP were genotyped. Sixty-three subjects (52.5%) had at least 1 reportable variant identified. For modeling the development of pancreatic endocrine insufficiency at 1 year, 6 were excluded (2 with DM at baseline, 3 with total pancreatectomy, and 1 death). From this group of 114, 95 remained normoglycemic and 19 (17%) developed endocrine insufficiency (4 DM, 15 pre-DM). Severe AP (58% vs 20%; P = .001) and at least 1 gene affected (79% vs 47%; P = .01) were enriched among the endocrine-insufficient group. Those with versus without endocrine insufficiency were similar in age, sex, race, ethnicity, body mass index, and AP recurrence. A model for pre-DM/DM development included AP severity (odds ratio, 5.17 [1.66-16.15]; P = .005) and genetic risk score (odds ratio, 4.89 [1.83-13.08]; P = .002) and had an area under the curve of 0.74.
In this cohort of children with AP, pancreatitis risk genes and AP disease severity were associated with pre-DM or DM development post-AP.
急性胰腺炎(AP)越来越被认为是糖尿病(DM)的危险因素。我们旨在研究胰腺炎基因与儿童 AP 后胰腺内分泌功能不全(糖尿病前期和 DM)发展之间的关系。
这是一项观察性队列研究,纳入了首次发作 AP 的≤21 岁的受试者,并对其进行了 12 个月的随访,以观察胰腺内分泌功能不全的发生。对胰腺炎风险基因(CASR、CEL、CFTR、CLDN2、CPA1、CTRC、PRSS1、SBDS、SPINK1 和 UBR1)进行测序。根据单变量 P <.15 的所有基因得出遗传风险评分。
共对 120 例 AP 患者进行了基因分型。63 例(52.5%)患者至少发现了 1 种可报告的变异。在对 1 年时胰腺内分泌功能不全的发展进行建模时,排除了 6 例(基线时有 2 例患有 DM,3 例接受了全胰切除术,1 例死亡)。在这组 114 例患者中,95 例仍保持血糖正常,19 例(17%)发展为内分泌功能不全(4 例 DM,15 例糖尿病前期)。内分泌功能不全组中严重 AP(58% vs 20%;P =.001)和至少 1 种基因受累(79% vs 47%;P =.01)的比例更高。有和没有内分泌功能不全的患者在年龄、性别、种族、民族、体重指数和 AP 复发方面无差异。DM/糖尿病前期发展的模型包括 AP 严重程度(比值比,5.17 [1.66-16.15];P =.005)和遗传风险评分(比值比,4.89 [1.83-13.08];P =.002),曲线下面积为 0.74。
在这项患有 AP 的儿童队列研究中,胰腺炎风险基因和 AP 疾病严重程度与 AP 后糖尿病前期或 DM 的发展相关。